Epoch Biodesign raised €17M in a Series A round in Mar 2025. The company is based in UK. Investors in the round: Day One Ventures, Extantia Capital, Happiness Capital and 4 others. Data as of 6 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.